Vicarious Surgical (NYSE:RBOT) Stock Price Up 15.8% – What’s Next?

Vicarious Surgical Inc. (NYSE:RBOT)’s stock price was up 15.8% during mid-day trading on Wednesday . The stock traded as high as $0.2205 and last traded at $0.22. 12,601 shares changed hands during mid-day trading, a decline of 84% from the average daily volume of 77,473 shares. The stock had previously closed at $0.19.

Wall Street Analyst Weigh In

Separately, Wall Street Zen cut shares of Vicarious Surgical from a “hold” rating to a “sell” rating in a research report on Saturday, March 7th. Two analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Vicarious Surgical presently has a consensus rating of “Reduce” and an average target price of $7.00.

Vicarious Surgical Trading Down 6.1%

The business’s 50-day simple moving average is $0.60 and its two-hundred day simple moving average is $1.36. The company has a market capitalization of $1.36 million, a PE ratio of -0.02 and a beta of 1.75.

Institutional Investors Weigh In On Vicarious Surgical

Hedge funds have recently bought and sold shares of the business. Dimensional Fund Advisors LP boosted its stake in shares of Vicarious Surgical by 22.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock valued at $110,000 after buying an additional 3,615 shares during the last quarter. Geode Capital Management LLC raised its holdings in Vicarious Surgical by 26.0% in the fourth quarter. Geode Capital Management LLC now owns 40,494 shares of the company’s stock valued at $88,000 after acquiring an additional 8,344 shares in the last quarter. XTX Topco Ltd acquired a new stake in Vicarious Surgical in the fourth quarter valued at $27,000. Connective Capital Management LLC bought a new position in Vicarious Surgical during the 3rd quarter valued at $169,000. Finally, Jane Street Group LLC bought a new position in Vicarious Surgical during the 4th quarter valued at $98,000. Institutional investors and hedge funds own 47.27% of the company’s stock.

About Vicarious Surgical

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.